Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-10-26

FDA Approved: NARATRIPTAN — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Naratriptan by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., permitting the sale of Naratriptan as …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naratriptan (Naratriptan)

Snippet

SUPPL AP for NARATRIPTAN (NARATRIPTAN)